» Articles » PMID: 34730997

Macrophages Orchestrate the Expansion of a Proangiogenic Perivascular Niche During Cancer Progression

Abstract

Tumor-associated macrophages (TAMs) are a highly plastic stromal cell type that support cancer progression. Using single-cell RNA sequencing of TAMs from a spontaneous murine model of mammary adenocarcinoma (), we characterize a subset of these cells expressing lymphatic vessel endothelial hyaluronic acid receptor 1 (Lyve-1) that spatially reside proximal to blood vasculature. We demonstrate that Lyve-1 TAMs support tumor growth and identify a pivotal role for these cells in maintaining a population of perivascular mesenchymal cells that express α-smooth muscle actin and phenotypically resemble pericytes. Using photolabeling techniques, we show that mesenchymal cells maintain their prevalence in the growing tumor through proliferation and uncover a role for Lyve-1 TAMs in orchestrating a selective platelet-derived growth factor–CC–dependent expansion of the perivascular mesenchymal population, creating a proangiogenic niche. This study highlights the inter-reliance of the immune and nonimmune stromal network that supports cancer progression and provides therapeutic opportunities for tackling the disease.

Citing Articles

Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets.

Guan F, Wang R, Yi Z, Luo P, Liu W, Xie Y Signal Transduct Target Ther. 2025; 10(1):93.

PMID: 40055311 PMC: 11889221. DOI: 10.1038/s41392-025-02124-y.


Functional biomaterials for biomimetic 3D in vitro tumor microenvironment modeling.

Ahmed T In Vitro Model. 2025; 2(1-2):1-23.

PMID: 39872875 PMC: 11756483. DOI: 10.1007/s44164-023-00043-2.


Mouse and human macrophages and their roles in cardiovascular health and disease.

Gallerand A, Han J, Ivanov S, Randolph G Nat Cardiovasc Res. 2024; 3(12):1424-1437.

PMID: 39604762 DOI: 10.1038/s44161-024-00580-3.


Targeting of TAMs: can we be more clever than cancer cells?.

Kzhyshkowska J, Shen J, Larionova I Cell Mol Immunol. 2024; 21(12):1376-1409.

PMID: 39516356 PMC: 11607358. DOI: 10.1038/s41423-024-01232-z.


PTEN Loss Shapes Macrophage Dynamics in High-Grade Serous Ovarian Carcinoma.

Spear S, Le Saux O, Mirza H, Iyer N, Tyson K, Grundland Freile F Cancer Res. 2024; 84(22):3772-3787.

PMID: 39186679 PMC: 7616669. DOI: 10.1158/0008-5472.CAN-23-3890.


References
1.
DeNardo D, Barreto J, Andreu P, Vasquez L, Tawfik D, Kolhatkar N . CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell. 2009; 16(2):91-102. PMC: 2778576. DOI: 10.1016/j.ccr.2009.06.018. View

2.
Davidson S, Efremova M, Riedel A, Mahata B, Pramanik J, Huuhtanen J . Single-Cell RNA Sequencing Reveals a Dynamic Stromal Niche That Supports Tumor Growth. Cell Rep. 2020; 31(7):107628. PMC: 7242909. DOI: 10.1016/j.celrep.2020.107628. View

3.
Mitchem J, Brennan D, Knolhoff B, Belt B, Zhu Y, Sanford D . Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. Cancer Res. 2012; 73(3):1128-41. PMC: 3563931. DOI: 10.1158/0008-5472.CAN-12-2731. View

4.
Etzerodt A, Tsalkitzi K, Maniecki M, Damsky W, Delfini M, Baudoin E . Specific targeting of CD163 TAMs mobilizes inflammatory monocytes and promotes T cell-mediated tumor regression. J Exp Med. 2019; 216(10):2394-2411. PMC: 6781002. DOI: 10.1084/jem.20182124. View

5.
Zhang L, Li Z, Skrzypczynska K, Fang Q, Zhang W, OBrien S . Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer. Cell. 2020; 181(2):442-459.e29. DOI: 10.1016/j.cell.2020.03.048. View